Lund University Hospital
A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.
Mycosis Fungoides
Cesarean Syndrome
Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.
| Study Type : | OBSERVATIONAL |
| Estimated Enrollment : | 120 participants |
| Official Title : | Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome. |
| Actual Study Start Date : | 2021-04-02 |
| Estimated Primary Completion Date : | 2027-04 |
| Estimated Study Completion Date : | 2027-04 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 18 Years to 100 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Lund University Hospital
Lund, Sweden, SE-221 85